Related Experiment Video
Updated: Oct 10, 2025
13:24
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
12.0K
Artificial intelligence, molecular subtyping, biomarkers, and precision oncology
1Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, U.S.A.
Emerging Topics in Life Sciences
|December 9, 2021
Summary
Precision oncology requires accurate tumor identification for targeted cancer therapies. This review explores the evolution of targeted treatments, biomarker development, and challenges in implementing molecularly defined cancer subtypes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Targeted cancer therapies necessitate precise identification of susceptible tumors.
- The development of targeted treatments has driven the classification of tumors into molecular subtypes.
- Traditional tumor classifications are evolving towards molecularly defined subtypes.
Purpose of the Study:
- To review the co-evolution of targeted therapies and biomarkers.
- To examine current methods for identifying molecular tumor subtypes.
- To discuss challenges and solutions for implementing precision oncology.
Main Methods:
- Literature review of targeted therapies and biomarkers.
- Analysis of current molecular subtype identification techniques.
- Discussion of implementation challenges in precision oncology.
Main Results:
- Paired evolution of targeted therapies and biomarkers is a key trend.
- Various methods exist for molecular subtype identification.
- Significant challenges impede the widespread adoption of precision oncology.
Conclusions:
- Accurate biomarker-driven tumor identification is crucial for effective targeted therapy.
- Overcoming implementation hurdles is essential for advancing precision oncology.
- Continued research into molecular subtypes will refine cancer treatment strategies.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
5.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.2K
01:20Applications of Molecular Taxonomy
187
Molecular taxonomy has revolutionized the understanding and classification of bacteria, providing precise insights into their diversity, evolutionary relationships, and ecological roles. By utilizing molecular techniques such as DNA sequencing and fingerprinting, researchers have made significant strides in various fields related to bacterial studies.Resolving Taxonomic AmbiguitiesMolecular taxonomy has been instrumental in distinguishing closely related bacterial species initially thought to...
187
01:29Modern Molecular Taxonomy
248
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
248